HB3359

Oklahoma HB3359 makes biomarker testing coverage in Medicaid discretionary, with specific timelines for prior authorization.

Oklahoma HB3359 amends the state Medicaid program to make biomarker testing coverage discretionary. It requires contracted entities to provide biomarker testing at the same scope, duration, and frequency as other Medicaid services. If prior authorization is needed, contracted entities must respond within 72 hours for non-urgent requests and 24 hours for urgent ones. The bill also ensures members and providers have access to clear processes for requesting biomarker testing.